{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T01:01:59Z","timestamp":1784336519515,"version":"3.55.0"},"reference-count":75,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Rheumatic Disease Clinics of North America"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1016\/j.rdc.2010.05.007","type":"journal-article","created":{"date-parts":[[2010,8,4]],"date-time":"2010-08-04T05:15:04Z","timestamp":1280898904000},"page":"609-621","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["The Future of ANCA-associated Vasculitis"],"prefix":"10.1016","volume":"36","author":[{"given":"Julia U.","family":"Holle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Wieczorek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang L.","family":"Gross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rdc.2010.05.007_bib1","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1136\/bmj.2.5091.265","article-title":"Giant cell granuloma of the respiratory tract (Wegener's granulomatosis)","volume":"2","author":"Walton","year":"1958","journal-title":"Br Med J"},{"key":"10.1016\/j.rdc.2010.05.007_bib2","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1056\/NEJM197908023010503","article-title":"Cyclophosphamide therapy of severe systemic necrotizing vasculitis","volume":"301","author":"Fauci","year":"1979","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rdc.2010.05.007_bib3","first-page":"350","article-title":"Autoantibodies against cytoplasmic structures of neutrophil granulocytes in Wegener's granulomatosis","volume":"69","author":"L\u00fcdemann","year":"1987","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.rdc.2010.05.007_bib4","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.1073\/pnas.87.11.4115","article-title":"Anti-neutrophil cytoplasmatic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro","volume":"87","author":"Falk","year":"1990","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.rdc.2010.05.007_bib5","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1189\/jlb.0104054","article-title":"ANCA induces beta2 integrin and CXC chemokine-dependent neutrophil-endothelial cell interactions that mimic those of highly cytokine-activated endothelium","volume":"77","author":"Calderwood","year":"2005","journal-title":"J\u00a0Leukoc Biol"},{"key":"10.1016\/j.rdc.2010.05.007_bib6","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1172\/JCI0215918","article-title":"Antineutrophil cytoplasmatic antibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice","volume":"110","author":"Xiao","year":"2002","journal-title":"J\u00a0Clin Invest"},{"issue":"2","key":"10.1016\/j.rdc.2010.05.007_bib7","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/art.1780370206","article-title":"Nomenclature of systemic vasculitides. Proposal of an international consensus conference","volume":"37","author":"Jennette","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2010.05.007_bib8","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1002\/art.1780330812","article-title":"The American College of Rheumatology 1990 criteria for the classification of vasculitis. Summary","volume":"33","author":"Fries","year":"1990","journal-title":"Arthritis Rheum"},{"issue":"Suppl 1","key":"10.1016\/j.rdc.2010.05.007_bib9","first-page":"29","article-title":"European therapeutic trials in ANCA-associated systemic vasculitis: disease scoring, consensus regimens and proposed clinical trials","volume":"101","author":"Rasmussen","year":"1995","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.rdc.2010.05.007_bib10","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1136\/ard.2006.062711","article-title":"EULAR recommendations for conducting clinical studies and\/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis","volume":"66","author":"Hellmich","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2010.05.007_bib11","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1136\/ard.2008.088096","article-title":"EULAR recommendations for the management of primary small vessel vasculitis","volume":"68","author":"Mukhtyar","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2010.05.007_bib12","first-page":"671","article-title":"Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis","volume":"87","author":"Luqmani","year":"1994","journal-title":"QJM"},{"key":"10.1016\/j.rdc.2010.05.007_bib13","first-page":"31","article-title":"Development and validation of a Disease Extent Index for Wegener's granulomatosis","volume":"55","author":"De Groot","year":"2001","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.rdc.2010.05.007_bib14","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/art.1780400222","article-title":"Development and initial validation of the Vasculitis Damage Index for the standardized clinical assessment of damage in the systemic vasculitides","volume":"40","author":"Exley","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2010.05.007_bib15","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/j.1365-2796.2008.02060.x","article-title":"Improved outcome in Wegener's granulomatosis and microscopic polyangiitis? A retrospective analysis of 95 cases in two cohorts","volume":"265","author":"Eriksson","year":"2009","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.rdc.2010.05.007_bib16","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1177\/039463200802100317","article-title":"Improvement in relative survival of patients with vasculitis: study of 101 cases compared to the general population","volume":"21","author":"Stratta","year":"2008","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.rdc.2010.05.007_bib17","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1038\/ki.1993.186","article-title":"Alpha 1-antitrypsin genetic polymorphism in ANCA-positive systemic vasculitis","volume":"43","author":"Esnault","year":"1993","journal-title":"Kidney Int"},{"key":"10.1016\/j.rdc.2010.05.007_bib18","doi-asserted-by":"crossref","unstructured":"Mahr AD, Edberg J, Stone J, et al. Alpha 1-antitrypsin deficiency and the risk for Wegener's granulomatosis. In: Proceedings of the 14th International Vasculitis and ANCA Workshop [abstract N1]. APMIS 2009;117(Suppl 127):157.","DOI":"10.1111\/j.1600-0463.2009.02476.x"},{"key":"10.1016\/j.rdc.2010.05.007_bib19","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/s00439-004-1092-z","article-title":"New genomic region for Wegener's granulomatosis as revealed by an extended association screen with 202 apoptosis-related genes","volume":"114","author":"Jagiello","year":"2004","journal-title":"Hum Genet"},{"key":"10.1016\/j.rdc.2010.05.007_bib20","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1136\/ard.2007.077693","article-title":"The Wegener's granulomatosis quantitative trait locus on chromosome 6p21.3 as characterized by tagSNP genotyping","volume":"67","author":"Heckmann","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2010.05.007_bib21","doi-asserted-by":"crossref","first-page":"4039","DOI":"10.1002\/art.21487","article-title":"The PTPN22 620W allele is a risk factor for Wegener's granulomatosis","volume":"12","author":"Jagiello","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2010.05.007_bib22","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1146\/annurev.immunol.021908.132653","article-title":"Recent advances in the genetics of autoimmune disease","volume":"27","author":"Gregersen","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.rdc.2010.05.007_bib23","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.4049\/jimmunol.0713370","article-title":"Cutting edge: the PTPN22 allelic variant associated with autoimmunity impairs B cell signaling","volume":"182","author":"Arechiga","year":"2009","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.rdc.2010.05.007_bib24","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/1471-2350-10-121","article-title":"Confirmation of the genetic association of CTLA4 and PTPN22 with ANCA-associated vasculitis","volume":"10","author":"Carr","year":"2009","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.rdc.2010.05.007_bib25","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/art.23209","article-title":"Associations of the Churg-Strauss syndrome with the HLA-DRB1 locus, and relationship to the genetics of anti-neutrophil cytoplasmic antibody-associated vasculitides: comment on the article by Vaglio et al","volume":"58","author":"Wieczorek","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2010.05.007_bib26","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1002\/art.22834","article-title":"HLA-DRB4 as a genetic risk factor for Churg-Strauss syndrome","volume":"56","author":"Vaglio","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2010.05.007_bib27","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00109-009-0580-y","article-title":"A\u00a0functionally relevant IRF5 haplotype is associated with reduced risk to Wegener's granulomatosis","volume":"88","author":"Wieczorek","year":"2010","journal-title":"J\u00a0Mol Med"},{"key":"10.1016\/j.rdc.2010.05.007_bib28","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1002\/art.23496","article-title":"Functionally relevant variations of the interleukin-10 gene associated with antineutrophil cytoplasmic antibody-negative Churg-Strauss syndrome","volume":"58","author":"Wieczorek","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2010.05.007_bib29","doi-asserted-by":"crossref","first-page":"52","DOI":"10.2353\/ajpath.2007.060573","article-title":"Alternative complement pathway in the pathogenesis of disease mediated by antineutrophil cytoplasmic autoantibodies","volume":"170","author":"Xiao","year":"2007","journal-title":"Am J Pathol"},{"key":"10.1016\/j.rdc.2010.05.007_bib30","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/nm.1874","article-title":"Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis","volume":"14","author":"Kain","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.rdc.2010.05.007_bib31","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1681\/ASN.V1061224","article-title":"A\u00a0large subset of neutrophils expressing membrane proteinase 3 is a risk factor for vasculitis and rheumatoid arthritis","volume":"10","author":"Witko-Sarsat","year":"1999","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.rdc.2010.05.007_bib32","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1097\/01.ASN.0000028642.26222.00","article-title":"Neutrophil membrane expression of proteinase 3 (PR3) is related to relapse in PR3-ANCA-associated vasculitis","volume":"13","author":"Rarok","year":"2002","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.rdc.2010.05.007_bib33","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/01.shk.0000223122.11147.5a","article-title":"Proteinase 3 expression on neutrophil membranes from patients with infectious disease","volume":"26","author":"Matsumoto","year":"2006","journal-title":"Shock"},{"key":"10.1016\/j.rdc.2010.05.007_bib34","doi-asserted-by":"crossref","first-page":"12","DOI":"10.7326\/0003-4819-120-1-199401010-00003","article-title":"Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener granulomatosis","volume":"120","author":"Stegeman","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.rdc.2010.05.007_bib35","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/rheumatology\/kep026","article-title":"Infection and vasculitis","volume":"48","author":"Belizna","year":"2009","journal-title":"Rheumatology"},{"key":"10.1016\/j.rdc.2010.05.007_bib36","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/1529-0131(200001)43:1<226::AID-ANR27>3.0.CO;2-Q","article-title":"Subacute bacterial endocarditis with positive cytoplasmatic antineutrophil cytoplasmatic antibodies and anti-proteinase 3 antibodies","volume":"43","author":"Choi","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2010.05.007_bib37","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1440-1797.2009.01100.x","article-title":"Drug-induced antineutrophil cytoplasmic antibody-associated vasculitis","volume":"14","author":"Gao","year":"2009","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.rdc.2010.05.007_bib38","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/BOR.0b013e3282f1331f","article-title":"Drug-induced vasculitis","volume":"20","author":"Wiik","year":"2008","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.rdc.2010.05.007_bib39","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1046\/j.1365-2133.2000.03445.x","article-title":"Myeloperoxidase-antineutrophil cytoplasmic antibody-associated vasculitis following propylthiouracil therapy","volume":"142","author":"Otsuka","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.rdc.2010.05.007_bib40","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1002\/art.11223","article-title":"Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis","volume":"48","author":"Rantap\u00e4a-Dahlqvist","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2010.05.007_bib41","doi-asserted-by":"crossref","first-page":"4440","DOI":"10.1182\/blood-2005-05-1875","article-title":"Wegener autoantigen induces maturation of dendritic cells and licenses them for Th1 priming via protease-activated receptor-2 pathway","volume":"107","author":"Csernok","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.rdc.2010.05.007_bib42","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1471-2172-9-34","article-title":"CpG oligodeoxynucleotide stimulates production of antineutrophil cytoplasmic antibodies in ANCA associated vasculitis","volume":"9","author":"Hurtado","year":"2008","journal-title":"BMC Immunol"},{"key":"10.1016\/j.rdc.2010.05.007_bib43","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/BOR.0b013e328332c9e4","article-title":"Pathogenesis of small-vessel vasculitis associated with autoantibodies to neutrophil cytoplasmic antigens: new insights from animal models","volume":"22","author":"Kain","year":"2010","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.rdc.2010.05.007_bib44","doi-asserted-by":"crossref","first-page":"5305","DOI":"10.1016\/j.febslet.2005.08.056","article-title":"Differences between human proteinase 3 and neutrophil elastase and their murine homologues are relevant for murine model experiments","volume":"579","author":"Wiesner","year":"2005","journal-title":"FEBS Lett"},{"key":"10.1016\/j.rdc.2010.05.007_bib45","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1136\/ard.2006.064626","article-title":"Rats and mice immunised with chimeric human\/mouse proteinase 3 produce autoantibodies to mouse PR3 and rat granulocytes","volume":"66","author":"Van der Geld","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2010.05.007_bib46","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1182\/blood-2004-01-0267","article-title":"Antineutrophil cytoplasmic autoantibodies against the murine homolog of proteinase 3 (Wegener autoantigen) are pathogenic in vivo","volume":"104","author":"Pfister","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.rdc.2010.05.007_bib47","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S0046-8177(81)80027-5","article-title":"The protracted superficial phenomenon in pathergic (Wegener's) granulomatosis","volume":"12","author":"Fienberg","year":"1981","journal-title":"Hum Pathol"},{"key":"10.1016\/j.rdc.2010.05.007_bib48","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/oxfordjournals.qjmed.a030133","article-title":"Response to trimethoprim\/sulfamethoxazole in Wegener's granulomatosis depends on the phase of disease","volume":"89","author":"Reinhold-Keller","year":"1996","journal-title":"QJM"},{"issue":"5","key":"10.1016\/j.rdc.2010.05.007_bib49","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1002\/1529-0131(200005)43:5<1021::AID-ANR10>3.0.CO;2-J","article-title":"An interdisciplinary approach to the care of patients with Wegener's granulomatosis: long-term outcome in 155 patients","volume":"43","author":"Reinhold-Keller","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2010.05.007_bib50","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1196\/annals.1361.042","article-title":"Is PR3-ANCA formation initiated in Wegener's granulomatosis lesions? Granulomas as potential lymphoid tissue maintaining antibody production","volume":"1051","author":"Voswinkel","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.rdc.2010.05.007_bib51","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1136\/ard.2005.044909","article-title":"B\u00a0lymphocyte maturation in Wegener's granulomatosis: a comparative analysis of VH genes from endonasal lesions","volume":"65","author":"Voswinkel","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2010.05.007_bib52","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/1529-0131(199904)42:4<742::AID-ANR18>3.0.CO;2-I","article-title":"Cytokine profiles in Wegener's granulomatosis: predominance of type 1 (Th1) in the granulomatous inflammation","volume":"42","author":"Csernok","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2010.05.007_bib53","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1001\/archinte.1989.00390110055012","article-title":"Association between active Wegener's granulomatosis and anticytoplasmatic antibodies","volume":"149","author":"Cohen Taervert","year":"1989","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.rdc.2010.05.007_bib54","doi-asserted-by":"crossref","first-page":"611","DOI":"10.7326\/0003-4819-147-9-200711060-00005","article-title":"Antiproteinase 3 antineutrophil cytoplasmatic antibodies and disease activity in Wegener granulomatosis","volume":"147","author":"Finkielman","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.rdc.2010.05.007_bib55","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S0140-6736(03)12269-6","article-title":"Circulating endothelial cells as markers for ANCA-associated small vessel vasculitis","volume":"361","author":"Woywodt","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.rdc.2010.05.007_bib56","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1093\/ndt\/gfn755","article-title":"Circulating angiopoietin-2 is a marker and potential mediator of endothelial cell detachment in ANCA-associated vasculitis with renal involvement","volume":"24","author":"K\u00fcmpers","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.rdc.2010.05.007_bib57","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1093\/rheumatology\/ken373","article-title":"Diagnostic role of endothelial microparticles in vasculitis","volume":"57","author":"Erdbr\u00fcgger","year":"2008","journal-title":"Rheumatology"},{"key":"10.1016\/j.rdc.2010.05.007_bib58","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1136\/ard.2005.040980","article-title":"Circulating endothelial cells in relapse and limited granulomatous disease due to ANCA-associated vasculitis","volume":"65","author":"Woywodt","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2010.05.007_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2007.09.049","article-title":"Circulating endothelial cells: a marker of vascular damage in patients with preeclampsia","volume":"198","author":"Grundmann","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.rdc.2010.05.007_bib60","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1002\/art.10312","article-title":"Elevated levels of platelet microparticles are associated with disease activity in rheumatoid arthritis","volume":"46","author":"Kniff-Dutmer","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2010.05.007_bib61","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1002\/art.21969","article-title":"Increased extracellular levels of the novel proinflammatory cytokine high mobility group box chromosomal protein 1 in minor salivary glands of patients with Sj\u00f6gren's syndrome","volume":"54","author":"Ek","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2010.05.007_bib62","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/BOR.0b013e328333390b","article-title":"Churg-Strauss syndrome: evidence for disease subtypes?","volume":"22","author":"Pagnoux","year":"2010","journal-title":"Curr Opin Rheumatol"},{"issue":"Suppl 10","key":"10.1016\/j.rdc.2010.05.007_bib63","first-page":"S204","article-title":"Rituximab versus cyclophosphamide for the induction of remission in ANCA-associated vasculitis: a randomized controlled trial (RAVE) [abstract 550]","volume":"60","author":"Stone","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"Suppl 127","key":"10.1016\/j.rdc.2010.05.007_bib64","first-page":"78","article-title":"Randomized trial of rituximab vs. cyclophosphamide for ANCA-associated renal vasculitis: RITUXVAS [abstract A24]","volume":"117","author":"Jones","year":"2009","journal-title":"APMIS"},{"key":"10.1016\/j.rdc.2010.05.007_bib65","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1365-2249.2009.03979.x","article-title":"Translational mini-review series on B cell-directed therapies: recent advances in B-cell-directed biological therapies for autoimmune disorders","volume":"157","author":"Levesque","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.rdc.2010.05.007_bib66","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jaut.2005.08.004","article-title":"BAFF is elevated in serum of patients with Wegener's granulomatosis","volume":"25","author":"Krumbholz","year":"2005","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.rdc.2010.05.007_bib67","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/BOR.0b013e328329a401","article-title":"Costimulation blockade in rheumatic diseases: where we are?","volume":"21","author":"Goeb","year":"2009","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.rdc.2010.05.007_bib68","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/1529-0131(200001)43:1<175::AID-ANR22>3.0.CO;2-S","article-title":"Disease-modifying activity of SB 242235, a selective inhibitor of p38 mitogen-activated protein kinase, in rat adjuvant-induced arthritis","volume":"43","author":"Badger","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2010.05.007_bib69","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.immuni.2007.04.011","article-title":"Spleen tyrosine kinase Syk is necessary for E-selection-induced alpha(L)beta2 integrin-mediated rolling on intercellular adhesion molecule-1","volume":"26","author":"Zarbock","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.rdc.2010.05.007_bib70","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1097\/01.ASN.0000113241.98702.77","article-title":"Activation of Syk in neutrophils by antineutrophil cytoplasm antibodies occurs via Fcgamma receptors and CD18","volume":"15","author":"Hewins","year":"2004","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.rdc.2010.05.007_bib71","first-page":"92","article-title":"The proteasome inhibitor bortezomib inhibits the release of NFKappaB-inducible cytokines and induces apoptosis of activated T-cells from rheumatoid arthritis patients","volume":"27","author":"van der Heijden","year":"2009","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.rdc.2010.05.007_bib72","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/nm1763","article-title":"The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis","volume":"14","author":"Neubert","year":"2008","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.rdc.2010.05.007_bib73","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJMoa041884","article-title":"Etanercept plus standard therapy for Wegener's granulomatosis","volume":"352","author":"Wegener's Granulomatosis Etanercept Trial (WGET) Research Group","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rdc.2010.05.007_bib74","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1056\/NEJMoa0802311","article-title":"Azathioprine of methotrexate maintenance for ANCA-associated vasculitis","volume":"359","author":"Pagnoux","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"Suppl 127","key":"10.1016\/j.rdc.2010.05.007_bib75","first-page":"77","article-title":"Randomized trial of mycophenolate mofetil vs. azathioprine for maintenance therapy in ANCA-associated vasculitides (AAV) [abstract A23]","volume":"117","author":"Hiemstra","year":"2009","journal-title":"APMIS"}],"container-title":["Rheumatic Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X10000505?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X10000505?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:10:57Z","timestamp":1760181057000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889857X10000505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":75,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S0889857X10000505"],"URL":"https:\/\/doi.org\/10.1016\/j.rdc.2010.05.007","relation":{},"ISSN":["0889-857X"],"issn-type":[{"value":"0889-857X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Future of ANCA-associated Vasculitis","name":"articletitle","label":"Article Title"},{"value":"Rheumatic Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rdc.2010.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}